Obalon Balloon System: Real-World Evidence Commercial Site Registry
Obalon Balloon System: Real-World Evidence Commercial Site Registry
Retrospective study of the data reported in the Obalon US Commercial Registry
Retrospective analyses of the safety and effectiveness data in the Obalon US Commercial Registry reported by participating clinics through August 28, 2018 from patients who started the Obalon therapy from January to December 2017 to represent the first year of commercialization. All patients included in the safety and efficacy analyses must have data through balloon removal and a starting BMI greater than or equal to 25, the definition of overweight and obese patients.
Inclusion Criteria: